Daily as of 3 Nov 16:00 ET
- Price
- between the two $9.88 vs 50 $11.06 / 200 $9.82
- Projection
- ๐Death cross estimated in 20 to 30 bars
- Test
- No active test
- Last cross
- ๐จGolden cross 22 Jun 2026 ยท projected 5 bars out
Kura Oncology (KURA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jun 2026, and a death cross is projected within 30 bars. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is below both.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | ๐Death | 4-hour | 20 bars out | Not tested |
| 22 Jun 2026 | ๐จGolden flat | daily | 5 bars out | Not tested |
| 5 May 2026 | ๐จGolden | 4-hour | 26 bars out | 1 bar cross test |
| 23 Mar 2026 | ๐Death moderate | daily | 13 bars out | 4 bar cross test |
| 22 Jan 2026 | ๐Death | 4-hour | 27 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.